Strategy's STRC Sits Below Parity for Fifth Month
STRC has traded under $100 since May despite Strategy's buybacks, and MSCI's delisting decision added further pressure.
The CSI 300 fell for a 10th straight week, its worst run since 2005, as AI and semiconductor stocks led the decline.
Last week, the CSI 300 index fell 3.4%, marking its 10th straight weekly loss — the longest such run since the benchmark's creation in 2005 — with AI stocks dragging the market lower.
The sell-off is being led by chipmakers and AI firms, which drove Beijing's spring rally earlier this year. The STAR 50 index, where five AI companies make up more than 30% of its weight, has tumbled 40% since June 30.
With 10 consecutive weeks of declines, this streak has surpassed the previous record of consecutive weekly losses set in January 2012.
Since reaching their highs this year, the three most widely followed Chinese stock indexes — the Shanghai Composite, Shenzhen Component, and CSI 300 — have shed 12%, 28%, and 17%, respectively.
An index of pure AI stocks has fallen 35% from its peak this year, a steeper drop than any of the above.
Semiconductors, which saw the biggest AI-fueled boom in the first half of 2024, are now suffering the deepest decline in the second half. The CSI All Share Semiconductors index has posted a 45% drawdown.
Bloomberg reported that no other major technology index globally has fared worse than the Star 50 since July 1.
In the third quarter, foreign investors pulled over $13 billion from mainland stocks via Hong Kong. That was the largest quarterly outflow in a year and wiped out more than half of the inflows seen in the spring.
The CSI 300 now trades 30% below its February 2021 high.
Share to
Disclaimer: this article comes from third-party media and is provided for reference only. It does not constitute investment advice. Crypto and other financial products carry significant price volatility risk, so please make your own decisions carefully.
STRC has traded under $100 since May despite Strategy's buybacks, and MSCI's delisting decision added further pressure.
Gemini shares hit a record-low $3.215 close, about 89% below the $28 IPO price; H1 2026 revenue rose and the loss narrowed.
A healthcare technology company is shifting most AI workloads to open-weight and small models, achieving major cost savings while maintaining performance.
Joe Lubin's Consensys sold all its SharpLink shares after a 94% stock collapse. The sale was at $8.39 per share, 93% below the peak.